Molecular Assembly and Stability of Human Hepatitis B Virus Surface Antigen Vaccine
人乙型肝炎病毒表面抗原疫苗的分子组装及稳定性
基本信息
- 批准号:02453151
- 负责人:
- 金额:$ 1.92万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (B)
- 财政年份:1990
- 资助国家:日本
- 起止时间:1990 至 1991
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Vaccines superior to the conventional ones can now be produced in principle using gene engineering technique. Human hepatitis B virus surface antigen vaccine derived from yeast(y-HBsAg vaccine)is, however, the first and only successful outcome of the introduction of the engineering technique into vaccine production. Its efficacy is believed to be derived from the particular nature and high stability of the assembly composed mainly of protein polypeptides and lipids. The present research project was motivated from our belief that the mode of assembly of the constituents and the source of the stability must be understood to provide basic knowledge hopefully leading to production other efficient vaccines through the approach.The y-HBsAg vaccine particles were found to be spherical, and homogeneous with respect to their size having radius of about 19 nm as judged from dynamic light scattering, small-angle X-ray scattering and electron microscopy. No regular structure was detected in the vaccine particle by small-angle X-ray scattering. The vaccine particle was eluted from a TSK-Gel G600OPW column as a symmetrical peak. Monitoring of the elution gave molar mass estimate of 5, 040 kg/mol for the vaccine particle of the target in the present study of which constituent polypeptide has 9 additional amino acid residues in the N-terminal side compared to the polypeptide of the virus surface antigen. The molar mass of the vaccine particle consisted of the latter polypeptide was estimated to be 4, 640 kg/ mol. The vaccine particle was stable against heating up to 8O゚C. The constituent polypeptide also showed stability against heating in the presence of SDS. Isoelectric point of the particle was estimated to be 4.0 to 4.2 by electrophoretic light scattering in free solution. It is hoped that these results and approaches can play a role of guidepost for future characterization of vaccine particles expected to be developed in near future using gene engineering technique.
然而,超过传统的疫苗可以从年份(y-hbsag疫苗)衍生出来,但是,安迪(Andy)的第一个成功结果是将工程技术引入疫苗的产生从我们的信念中激发了成分组装方式和稳定性的来源,必须理解以提供基本知识,希望通过方法能够导致生产其他有效的疫苗。关于它们的大小约为19 nm,是从动态光散射中判断的,而不是电子结构在本研究中,洗脱的摩尔质量估计值为5个靶标的摩尔元素,即与病毒表面抗原的多肽相比,N末端的征兵多肽9个额外的氨基酸性。为4,640 kg/ mol。最多8o。分为技术的疫苗。
项目成果
期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Takagi, T.: "New aspects of electrophoresis of membrane proteins" Electrophoretic light scattering and polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate. 391-406 (1990)
Takagi, T.:“膜蛋白电泳的新方面”十二烷基硫酸钠存在下的电泳光散射和聚丙烯酰胺凝胶电泳。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Keiichi Kameyama: "Measurement of electrophoretic mobilities of sodium dodecyl sulfate simple micelles and mixed micelles with nonionic surfactant,octaethylene glycol dodecyl ether,by electrophoretic light scattering with the correction for electroosmotic
Keiichi Kameyama:“通过电泳光散射测量十二烷基硫酸钠简单胶束和含有非离子表面活性剂辛二醇十二烷基醚的混合胶束的电泳迁移率,并进行电渗校正
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
高木 俊夫: "電気泳動光散乱法〜蛋白質から細胞までを対象とした新規装置について" 生物物理化学. 36. 1-11 (1992)
Toshio Takagi:“电泳光散射法 - 一种针对从蛋白质到细胞的一切的新装置”生物物理化学 36. 1-11 (1992)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yoshiko Sato,Nobuyoshi Ishikawa,Mamoru Sato,Keiichi Kameyama,Toshio Takagi: "Characterization of Yeastーderived Human Hepatitis B Vaccine Particle:Gross conformation and polypeptide compositin" Journal of Biochemistry.
Yoshiko Sato、Nobuyoshi Ishikawa、Mamoru Sato、Keiichi Kameyama、Toshio Takagi:“酵母源性人乙型肝炎疫苗颗粒的表征:总体构象和多肽合成”《生物化学杂志》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Keiichi Kameyama: "Measurement of electrophoretic mobilities of sodium dodecyl sulfate simple micelles and mixed micelles nonionic surfactant,octaethylene glycol dodecy ether,by electrophoretic light scattering with the correction for electroosmotic flow"
Keiichi Kameyama:“通过电泳光散射测量十二烷基硫酸钠简单胶束和混合胶束非离子表面活性剂辛二醇十二烷基醚的电泳迁移率,并校正电渗流”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TAKAGI Toshio其他文献
TAKAGI Toshio的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TAKAGI Toshio', 18)}}的其他基金
Capillary Electrophoresis Using Concentrated Solution of Oligomeric Saccharides as the Medium : Elucidation of the Mechanism of the Size-dependent Separation and Its Development
以寡聚糖浓溶液为介质的毛细管电泳:大小依赖性分离机制的阐明及其发展
- 批准号:
07640804 - 财政年份:1995
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Japanese-Swedish Cooperative Research on Bioseparation Science
日本与瑞典生物分离科学合作研究
- 批准号:
05044057 - 财政年份:1993
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for international Scientific Research
Development of Crosslinkage-free Linear Polymer Electrophoresis
无交联线性聚合物电泳的发展
- 批准号:
03558018 - 财政年份:1991
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
Development of a Schlieren Optics for Real-Time Visualization of Polyacrylamide Gel Electrophoresis
开发用于聚丙烯酰胺凝胶电泳实时可视化的纹影光学器件
- 批准号:
63880019 - 财政年份:1988
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B).
Control of Solubilized State and Estimation of Molecular Organization of Membrane Proteins by the Use of Analogues of Sodium Dodecyl Sulfate
使用十二烷基硫酸钠类似物控制溶解状态并估计膜蛋白的分子组织
- 批准号:
60470157 - 财政年份:1985
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似国自然基金
基因工程化仿生纳米囊泡的构建及肿瘤联合免疫治疗
- 批准号:22378429
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
光-热触发型基因工程菌增敏铁死亡协同强化肿瘤免疫治疗的研究
- 批准号:82303779
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于病毒样颗粒的脊髓灰质炎病毒基因工程疫苗的构建、免疫效果评价和作用机制研究
- 批准号:32370991
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
ABEmax碱基编辑器构建基因工程ICD治疗致心律失常性心肌病的研究
- 批准号:82370236
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
应用基因工程仓鼠模型探讨ApoA5在动脉粥样硬化中的作用及其机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Development of RespiraClear for targeted mucosal treatment of RSV infections
开发 RespiraClear 用于 RSV 感染的粘膜靶向治疗
- 批准号:
10319687 - 财政年份:2019
- 资助金额:
$ 1.92万 - 项目类别:
Development of RespiraClear for targeted mucosal treatment of RSV infections
开发 RespiraClear 用于 RSV 感染的粘膜靶向治疗
- 批准号:
10402916 - 财政年份:2019
- 资助金额:
$ 1.92万 - 项目类别:
Characterization of the arenavirus glycoprotein complex and mechanism of fusion
沙粒病毒糖蛋白复合物的表征和融合机制
- 批准号:
9021590 - 财政年份:2015
- 资助金额:
$ 1.92万 - 项目类别:
Magnetic Nanoparticles and Quantum Dots for Diagnosis of Early Stage Ovarian Canc
磁性纳米颗粒和量子点用于诊断早期卵巢癌
- 批准号:
8110007 - 财政年份:2010
- 资助金额:
$ 1.92万 - 项目类别:
Bioactive lipids in food and pharmaceutical products
食品和药品中的生物活性脂质
- 批准号:
8056822 - 财政年份:2010
- 资助金额:
$ 1.92万 - 项目类别: